Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Arrow Capital Pty Ltd Invests $3.36 Million in Merck & Co., Inc. $MRK
Arrow Capital Pty Ltd recently acquired 40,000 shares of Merck & Co., Inc. (NYSE:MRK) valued at approximately $3.36 million, making it the 25th largest holding in their portfolio. This investment aligns with a broader trend of institutional investors increasing their stakes in Merck, driven by bullish market sentiment following positive Phase 3 clinical trial data for belzutifan (WELIREG), analyst upgrades, and a declared quarterly dividend of $0.85. The company’s strong financial performance, pipeline potential, and favorable analyst ratings contribute to its appeal to investors.